Stryker Osake

Stryker EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Stryker (SYK) 16.8.2026 päivämäärällä on 5,62 Mrd. USD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 5,68 Mrd. USD — muutos −1,11 % (matalampi).

EBITDA

5,62 Mrd.USD

YoY

−1,11%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Stryker on 2026 5,62 Mrd. USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Stryker oli 2025 5,68 Mrd. USD. Se laskee −1,11% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Stryker Osakeanalyysi

Mitä Stryker tekee? Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Stryker osakkeesta

Yhtiön Stryker EBITDA (Tulos ennen korkoja, veroja ja poistoja) on 5,62 Mrd. USD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Stryker muuttui arvosta 5,68 Mrd. USD arvoon 5,62 Mrd. USD, mikä edustaa −1,11 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Stryker:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n USD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Stryker historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Stryker

Kaikki tunnusluvut — Stryker